Nanexa AB (publ) (STO: NANEXA)
Sweden
· Delayed Price · Currency is SEK
2.510
+0.090 (3.72%)
Dec 20, 2024, 5:23 PM CET
Nanexa AB Revenue
Nanexa AB had revenue of 11.12M SEK in the quarter ending September 30, 2024, a decrease of -19.13%. This brings the company's revenue in the last twelve months to 50.76M, down -1.69% year-over-year. In the year 2023, Nanexa AB had annual revenue of 59.16M with 117.72% growth.
Revenue (ttm)
50.76M
Revenue Growth
-1.69%
P/S Ratio
6.25
Revenue / Employee
3.17M
Employees
19
Market Cap
340.60M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 59.16M | 31.99M | 117.72% |
Dec 31, 2022 | 27.17M | 9.16M | 50.87% |
Dec 31, 2021 | 18.01M | -2.85M | -13.66% |
Dec 31, 2020 | 20.86M | 12.13M | 138.93% |
Dec 31, 2019 | 8.73M | 4.58M | 110.36% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 519.35B |
Swedish Orphan Biovitrum AB (publ) | 25.44B |
Sectra AB (publ) | 3.14B |
Getinge AB (publ) | 33.59B |
Camurus AB (publ) | 1.69B |
Vitrolife AB (publ) | 3.56B |
Medicover AB (publ) | 22.60B |
Bonesupport Holding AB (publ) | 814.46M |